Omkar Speciality Chemicals is locked at upper circuit limit at Rs. 27.25, up by 1.29 points or 4.97% from its previous closing of Rs. 25.96 on the BSE.
The scrip opened at Rs. 27.25 and has touched a high and low of Rs. 27.25 and Rs. 27.25 respectively. So far 2205 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 82.05 on 29-Jan-2018 and a 52 week low of Rs. 8.72 on 26-Oct-2018.
Last one week high and low of the scrip stood at Rs. 27.25 and Rs. 21.71 respectively. The current market cap of the company is Rs. 56.08 crore.
The promoters holding in the company stood at 27.62%, while Institutions and Non-Institutions held 0.01% and 72.38% respectively.
Omkar Speciality Chemicals (OSCL) has received its seventh Process Patent to produce ‘Halquinol’ product from the Intellectual Property India, The Government of India Patent office. The process is safe, economic and ecofriendly.
With this, the number of patents granted to OSCL till date stands at 7, and addition six more patents applications filed for other products are pending for grant.
Omkar Speciality Chemicals is one of the leading players in the manufacturing of Speciality Chemicals and Veterinary APIs. The company manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: